Acquisition of Exonics Therapeutics by Vertex Pharmaceuticals

Exonics Therapeutics was acquired by Vertex.

Overview Structured Data Issues Contributors Activity

pharmaceutical-technology.com/news/vertex-buys-exonics-therapeutics/

Is a

‌

Acquisition

Acquisition attributes

Acquired Company

Exonics Therapeutics

Acquirer

Vertex

Acquisition Amount (USD)

245,000,000

Date Announced

June 7, 2019

Exonics Therapeutics, a gene-editing therapies company, was acquired by Vertex Pharmaceutical. Vertex agreed to make an upfront payment of $245 million with a definitive agreement for milestone payments that can reach but not exceed $1 billion.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like Acquisition of Exonics Therapeutics by Vertex Pharmaceuticals

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API